ATX inhibitor 17
ATX inhibitor 17 is a potent ATX inhibitor with an IC50 of 0.019 μM. ATX inhibitor 17 shows excellent anti-proliferative activities in breast cancer cells.
For research use only. We do not sell to patients.
- CAS No.: 2750152-64-6
- Formula: C29H29F5N8S
- Molecular Weight:616.65
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
IC50: 0.019 µM (ATX)[1]
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
13.4 μM
Compound: 25a
|
Antiproliferative activity against human A549 cells measured after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells measured after 72 hrs by MTT assay
|
[PMID: 32535330] |
| MCF7 | IC50 |
1.01 μM
Compound: 25a
|
Antiproliferative activity against human MCF7 cells measured after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells measured after 72 hrs by MTT assay
|
[PMID: 32535330] |
| MDA-MB-231 | IC50 |
0.79 μM
Compound: 25a
|
Antiproliferative activity against human MDA-MB-231 cells measured after 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells measured after 72 hrs by MTT assay
|
[PMID: 32535330] |
| NCI-H2228 | IC50 |
>15 μM
Compound: 25a
|
Antiproliferative activity against human NCI-H2228 cells measured after 72 hrs by MTT assay
Antiproliferative activity against human NCI-H2228 cells measured after 72 hrs by MTT assay
|
[PMID: 32535330] |
In Vitro
ATX inhibitor 17 (compound 25a) (0-15 μM; 72 h) shows excellent anti-proliferative activities in breast cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MCF7, MDA-MB-231, A549, H2228 cells
-
Concentration:0-15 µM
-
Incubation Time:72 h
-
Result:Showed excellent antiproliferative effects with IC50s of 1.01, 0.79, 13.40, >15 µM for MCF7, MDA-MB-231, A549, H2228 cells, respectively.
Chemical Information
-
CAS No. 2750152-64-6
-
Molecular Weight 616.65
-
Formula C29H29F5N8S
-
SMILES
CC1=C(C2=CC(N3CCN(CC3)CCN(C)C)=C(C=C2N1)F)/C(C(F)(F)F)=N/NC4=NC(C5=CC=C(C=C5)F)=C(S4)C#N
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)